Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab

References

• MowatCColeAWindsorAIBD Section of the British Society of GastroenterologyGuidelines for the management of inflammatory bowel disease in adultsGut20116057160721464096
   PubMed Web of Science ®Google Scholar
• MeierJSturmACurrent treatment of ulcerative colitisWorld J Gastroenterol2011173204321221912469
   PubMed Web of Science ®Google Scholar
• OrdasIEckmannLTalaminiMBaumgartDCSandbornWJUlcerative colitisLancet201238016091619
   Web of Science ®Google Scholar
• ArmuzziAPuglieseDNardoneOMGuidiLManagement of difficult-to-treat patients with ulcerative colitis: focus on adalimumabDrug Des Devel Ther20137289296
   PubMed Web of Science ®Google Scholar
• IBD and ulcerative colitisBaylessTMHanauerSBAdvanced Therapy in Inflammatory Bowel DiseaseShelton, CTPeople’s Medical Publishing House20111621
   Google Scholar
• FreemanHJLimitations in assessment of mucosal healing in inflammatory bowel diseaseWorld J Gastroenterol201016152020039444
   PubMed Web of Science ®Google Scholar
• D’HaensGSandbornWJFeaganBGA review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitisGastroenterology200713276378617258735
   PubMed Web of Science ®Google Scholar
• KornbluthASacharDBUlcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters CommitteeAm J Gastroenterol2004991371138515233681
   PubMed Web of Science ®Google Scholar
• GeboesKDalleIInfluence of treatment on morphological features of mucosal inflammationGut200250Suppl 3III37III4211953331
   PubMedGoogle Scholar
• VillanacciVAntonelliEGeboesKCasellaGBassottiGHistological healing in inflammatory bowel disease: a still unfulfilled promiseWorld J Gastroenterol20131996897823467585
   PubMed Web of Science ®Google Scholar
• FrøslieKFJahnsenJMoumBAVatnMHIBSEN GroupMucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohortGastroenterology200713341242217681162
   PubMed Web of Science ®Google Scholar
• ZallotCPeyrin-BirouletLDeep remission in inflammatory bowel disease: looking beyond symptomsCurr Gastroenterol Rep20131531523354742
   PubMedGoogle Scholar
• ColombelJFLouisEPeyrin-BirouletLSandbornWJPanaccioneRDeep remission: a new concept?Dig Dis201230Suppl 310711123295700
   PubMed Web of Science ®Google Scholar
• TrueloveSCWittsCJCortisone in ulcerative colitis. Final report on a therapeutic trialBr Med J1955ii1041104813260656
   PubMed Web of Science ®Google Scholar
• SandbornWJTravisSMoroLOnce-daily budesonide MMX extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE 1studyGastroenterology20121431218122622892337
   PubMed Web of Science ®Google Scholar
• ThomsonABGuptaMFreemanHJUse of the tumor necrosis factor-blockers for Crohn’s diseaseWorld J Gastroenterol2012184823485423002356
   PubMed Web of Science ®Google Scholar
• RutgeertsPSandbornWJFeaganBGInfliximab for induction and maintenance therapy for ulcerative colitisN Engl J Med20053532462247616339095
   PubMed Web of Science ®Google Scholar
• LoflandJHMallowPRizzoJCost-per-remission analysis of infliximab compared to adalimumab among adults with moderate-to-severe colitisJ Med Econ20131646146723445401
   PubMedGoogle Scholar
• SandbornWJFeaganBGMaranoCSubcutaneous golimumab induces clinical response and remission in patients with moderate to severe ulcerative colitisGastroenterologyJune22013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• SandbornWJFeaganBGMaranoCSubcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitisGastroenterologyJune132013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• ReinischWSandbornWJHommesDWAdalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomized controlled trialGut20116078078721209123
   PubMed Web of Science ®Google Scholar
• SandbornWJvan AsscheGReinischWAdalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisGastroenterology201214225726522062358
   PubMed Web of Science ®Google Scholar
• SandbornWJColombelJFD’HaensGOne-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2Aliment Pharmacol Ther20133720421323173821
   PubMed Web of Science ®Google Scholar
• McDermottEMurphySKeeganDO’DonoghueDMulcahyHDohertyGEfficacy of adalimumab as a long term maintenance therapy in ulcerative colitisJ Crohns Colitis2013715015322520592
   PubMed Web of Science ®Google Scholar
• FreemanHJErythema nodosum and pyoderma gangrenosum in 50 patients with Crohn’s diseaseCan J Gastroenterol20051960360616247522
   PubMed Web of Science ®Google Scholar
• Arguelles-AriasFCastro-LariaLLobatonTCharacteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseDig Dis Sci2013582949295423828140
   PubMed Web of Science ®Google Scholar
• Barreiro-de AcostaMGarcia-BoschOGordilloJEfficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case seriesEur J Gastroenterol Hepatol20122475675822395225
   PubMed Web of Science ®Google Scholar
• DeepakPStobaughDJSheridMSifuentesHEhrenpreisEDNeurological events with tumor necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting SystemAliment Pharmacol Ther20133838839623802849
   PubMed Web of Science ®Google Scholar
• TursiAPennaAOnset of ulcerative colitis under treatment with adalimumabAm J Gastroenterol20081032410241218844636
   PubMed Web of Science ®Google Scholar
• GisbertJPChaparroMSafety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel diseaseAm J Gastroenterol20131081426143823752881
   PubMed Web of Science ®Google Scholar
• MelmedGYIppolitiAFPapdakisKAPatients with inflammatory bowel disease are at risk for vaccine-preventable illnessesAm J Gastroenterol20061011834184016817843
   PubMed Web of Science ®Google Scholar
• SandsBECuffariCKatzJGuidelines for immunizations in patients with inflammatory bowel diseaseInflamm Bowel Dis20041067769215472534
   PubMed Web of Science ®Google Scholar
• FeaganBGRutgeertsPSandsBEVedolizumab as induction and maintenance therapy for ulcerative colitisN Engl J Med201336969971023964932
   PubMed Web of Science ®Google Scholar
• DeclerckPJBiosimilar monoclonal antibodies: a science-based regulatory challengeExp Opin Biol Ther201313153156
   PubMed Web of Science ®Google Scholar